BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2025 9:01:59 AM | Browse: 243 | Download: 986
Publication Name World Journal of Gastrointestinal Surgery
Manuscript ID 109980
Country China
ISSN 1948-9366 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Clinical Trials Study
Article Title Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial
Manuscript Source Unsolicited Manuscript
All Author List Xian Qin, Jing Chen, Hua-Ni Zhang, Li Du, Yan Ma, Yi Li, Yu Lu, Ya-Ting Wang, Liu-Fang Wu, Zi-Hui Yu, Meng-Jing Hu, Li-Jun Li, Bo Liao, Zhen Li, Zhi-Yong Yang, Kun Li and Yu-Feng Yuan
ORCID
Author(s) ORCID Number
Zhen Li http://orcid.org/0000-0002-0464-1791
Zhi-Yong Yang http://orcid.org/0000-0002-5430-5024
Yu-Feng Yuan http://orcid.org/0000-0003-3924-3803
Funding Agency and Grant Number
Funding Agency Grant Number
Foundation of Health Commission of Hubei Province No. WJ2019H053
Natural Science Foundation of Hubei Province No. 2023AFB169
Foundation of Health Commission of Hubei Province No. ZY2021Q019
Open Fund Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital No. 2024SCOF008
Corresponding Author Yu-Feng Yuan, MD, Professor, Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road Wuchang District, Wuhan 430000, Hubei Province, China. yuanyf1971@whu.edu.cn
Key Words Umbilical cord-derived mesenchymal stem cells; Decompensated liver cirrhosis; Hepatitis virus B; Liver function; Clinical trial
Core Tip This pioneering trial demonstrates that peripheral vein infusion of human umbilical cord-derived mesenchymal stem cells provides rapid and durable liver function improvement in HBV-related decompensated cirrhosis. Key results include: (1) Improvement in liver function sustained for almost 3 months; (2) Coagulation improvement and interleukin-8 reduction sustained > 3 months; (3) 100% 6-month survival across all doses and exceptional 2-year survival (66.7%-100%); (4) Weak dose-efficacy correlation suggesting even low-dose efficacy; and (5) Promising safety profile. human umbilical cord-derived mesenchymal stem cells represent a novel therapy for end-stage liver disease, warranting large-scale validation.
Publish Date 2025-09-24 09:01
Citation

Qin X, Chen J, Zhang HN, Du L, Ma Y, Li Y, Lu Y, Wang YT, Wu LF, Yu ZH, Hu MJ, Li LJ, Liao B, Li Z, Yang ZY, Li K, Yuan YF. Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial. World J Gastrointest Surg 2025; 17(9): 109980

URL https://www.wjgnet.com/1948-9366/full/v17/i9/109980.htm
DOI https://dx.doi.org/10.4240/wjgs.v17.i9.109980
Full Article (PDF) WJGS-17-109980-with-cover.pdf